Get startedLog in
    Picture of Roivant Sciences logo

    ROIV — Roivant Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Roivant's lung disease drug fails mid-stage trial

    Picture of Roivant Sciences logoRoivant Sciences
    03/12/2024 12:05
    Dec 3 (Reuters) - Roivant  ROIV.O  said on Tuesday its
drug did not meet the main goal in a mid-stage trial evaluating
it in patients with a type of lung disease.

 (Reporting by Christy Santhosh in Bengaluru; Editing by
Shinjini Ganguli)
 ((Christy.Santhosh@thomsonreuters.com;))

    Recent news on Roivant Sciences

    See all news